Mortality News and Research

RSS

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Researchers designed a dynamic mathematical model to simulate the transmission of the SARS-CoV-2 Omicron variant in China and project its associated burden on healthcare facilities, should the zero-COVID-19 policy be lifted.

28 Mar 2022

Which U.S. cities are most vulnerable to spread of COVID-19?

Now, researchers from New Jersey City University have been attempting to explore the same factors to identify vulnerability in U.S. cities. Their research, under consideration at the journal Scientific Reports, is currently available on the Research Square* preprint server.

28 Mar 2022

Tuberculosis infection protects mice against COVID-19

To study if prior Mtb infection affects the response to CoV2 infection, K18-hACE2 (ACE2) and C57BL/6 (B6) mice were infected with Mtb, and post thirty days, were exposed to CoV2.

27 Mar 2022

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

Researchers discuss the results of a clinical trial to assess the efficacy and safety of IV sarilumab for the treatment of hospitalized COVID-19 patients.

27 Mar 2022

New approach to help low- and middle-income countries reduce premature mortality from NCDs

Most of the world's countries have made little progress towards a target adopted by the United Nations in 2015, which called for the world to reduce premature mortality from non-communicable diseases by a third by 2030.

27 Mar 2022

Exploring the vital connection between gut microbes, physical activity, and health

Our bowels accommodate billions of active microbes that affect the health, a fact that is arousing increasing interest also among athletes.

26 Mar 2022

Study: False positive mammograms are common after a decade of annual breast cancer screening

A study led by UC Davis Health has found that half of all women will experience at least one false-positive mammogram over a decade of annual breast cancer screening with digital breast tomosynthesis (3D mammography).

25 Mar 2022

How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

A new study has focussed on conducting a systematic search of the literature and aggregated data associated with randomized control trials of passive antibody therapy.

25 Mar 2022

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

A new study has focussed on screening and identification of possible SMIs of this PPI for COVID-19.

25 Mar 2022

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

A team of international scientists has developed an mRNA-based coronavirus disease 2019 (COVID-19) vaccine encoding the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant. The vaccine candidate has shown high efficacy in inducing neutralizing antibodies and protecting against delta infection in mice. The study is currently available on the bioRxiv* preprint server.

24 Mar 2022

IgG Fc glycosylation: A marker for severe COVID-19

Researchers suggest that low anti-spike IgG1 glycosylation, sialyation, and high bisection are markers of severe COVID-19.

24 Mar 2022

Brain fog in post-COVID Canadians

A new study confirms that a history of COVID-19 is a risk factor for cognitive dysfunction in the young and middle-aged.

24 Mar 2022

Breast milk components show potent in vitro SARS-CoV-2 inhibition

Human breastmilk contains substances that can inhibit infection by SARS-CoV-2 and its variants, as well as prevent its replication.

24 Mar 2022

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Antibiotic resistance is a growing problem worldwide that threatens the efficacy of available treatments and can lead to extended hospital stays and increased mortality.

24 Mar 2022

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Tuberculosis (TB) is a potentially serious infectious disease caused by a type of bacterium called Mycobacterium tuberculosis.

24 Mar 2022

INRS professor developing a glycoconjugate vaccine for melioidosis

The threat from Melioidosis is real. The bacterium that causes this infectious multisymptom illness is resistant to antibiotics, making diagnosis and treatment more complex and resulting in a mortality rate of up to 50%.

24 Mar 2022

Aspirin use associated with lower rates of death in hospitalized COVID-19 patients

Researchers at the George Washington University published findings from the world's largest cohort study showing that hospitalized patients with moderate COVID-19 who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin.

24 Mar 2022

Daily coffee intake associated with benefits to heart health

Drinking coffee - particularly two to three cups a day - is not only associated with a lower risk of heart disease and dangerous heart rhythms but also with living longer, according to studies being presented at the American College of Cardiology's 71st Annual Scientific Session.

24 Mar 2022

Impact of polystyrene microplastic particles on freshwater organisms

...

23 Mar 2022

Discovery of helpful proteins in the lung could lead to new treatment for respiratory failure

Scientists have discovered a new family of helpful proteins in the lung, with the finding potentially paving the way for a new course of treatment for patients with respiratory failure.

23 Mar 2022

Mortality News and Research

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Which U.S. cities are most vulnerable to spread of COVID-19?

Tuberculosis infection protects mice against COVID-19

Study evaluates efficacy of sarilumab in severe/critical COVID-19 patients

New approach to help low- and middle-income countries reduce premature mortality from NCDs

Exploring the vital connection between gut microbes, physical activity, and health

Study: False positive mammograms are common after a decade of annual breast cancer screening

How the timing and dose of different types of passive antibody treatments predict protection from SARS-CoV-2 infection

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

IgG Fc glycosylation: A marker for severe COVID-19

Brain fog in post-COVID Canadians

Breast milk components show potent in vitro SARS-CoV-2 inhibition

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

INRS professor developing a glycoconjugate vaccine for melioidosis

Aspirin use associated with lower rates of death in hospitalized COVID-19 patients

Daily coffee intake associated with benefits to heart health

Impact of polystyrene microplastic particles on freshwater organisms

Discovery of helpful proteins in the lung could lead to new treatment for respiratory failure

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News